PlumX Metrics
Embed PlumX Metrics

Current surgical treatment of non-small-cell lung cancer

Expert Review of Anticancer Therapy, ISSN: 1473-7140, Vol: 11, Issue: 10, Page: 1577-1585
2011
  • 13
    Citations
  • 0
    Usage
  • 20
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Most Recent News

Current Treatment Strategies in Nonsquamous Non-Small Cell Lung Cancer

NONSQUAMOUS NON‒SMALL CELL LUNG CANCER (NSCLC) is a heterogeneous disease with multiple treatment options dependent upon staging, presence of metastasis, and patient factors—including presence of

Review Description

When considering surgical treatment for non-small-cell lung cancer (NSCLC), a distinction is made between early-stage disease (stages IA/B and IIA/B), locoregionally advanced disease (stages IIIA/B) and metastatic disease (stage IV). Complete surgical resection of NSCLC can provide good long-term outcome. Surgery is considered the treatment of choice in patients with early-stage NSCLC or patients with T3N1 disease. Surgery for locoregionally advanced disease remains controversial. In specific cases of T4 disease, surgery can provide long-term survival. In patients with stage IIIA-N2 disease, surgery is only offered to patients who have achieved mediastinal downstaging following induction therapy. Careful preoperative evaluation is clearly important in the staging and selection of patients with NSCLC for surgery. © 2011 Expert Reviews Ltd.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know